MENU
PSTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Poseida Therapeutics (PSTX) Ownership - Who owns Poseida Therapeutics?

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need... Show more

Profile

Industry
N/A
Address
9390 Towne Centre Drive
Phone
+1 858 779-3100
Employees
330
Web
https://www.poseida.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
925.93M
P/E Ratio
N/A
Total Cash
230.85M
Projected Growth
N/A
Total Debt
82.73M
Revenue
150.86M
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash/Share
2.37
Total Debt/Equity
N/A
Revenue/Share
1.56 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors

Industry Biotechnology

Profile
Details
Industry
N/A
Address
9390 Towne Centre Drive
Phone
+1 858 779-3100
Employees
330
Web
https://www.poseida.com